17. Write in detail diagnostic and therapeutic importance of enzymes. Add flowchart

Reading File

Finding Sources

Reading File

Generating Image

Diagnostic and Therapeutic Importance of Enzymes

PART I: DIAGNOSTIC IMPORTANCE OF ENZYMES

1. Principle: Why Enzymes Appear in Blood During Disease

Under normal physiologic conditions, intracellular enzymes are present in serum at very low levels (their reference ranges reflect normal cell turnover). When cells are injured or destroyed, the steep concentration gradient between the cell interior and extracellular fluid drives intracellular enzymes out into the interstitial fluid and then into the bloodstream via capillary or lymphatic transfer.

The rate and pattern of enzyme release depends on:

Molecular size - smaller enzymes diffuse more rapidly
Intracellular location - cytosolic enzymes appear earlier than mitochondrial ones (mitochondrial enzyme release requires more severe injury)
Vascularization - hepatic enzymes pass directly through permeable capillaries; skeletal muscle enzymes primarily use lymphatic drainage
Half-life - determines how long elevations persist (e.g., ALT t½ = 47 hrs; AST t½ = 17 hrs for cytosolic, 87 hrs for mitochondrial)

"Disease processes that cause cell injury or death result in damage to the cell membrane, leading to the release of specific intracellular enzymes into tissue spaces and the microvasculature." - Henry's Clinical Diagnosis and Management by Laboratory Methods

2. Organ-Specific Enzyme Markers

A. Liver Disease

Enzyme	Significance
ALT (SGPT)	Most liver-specific; rises dramatically in acute hepatitis, viral hepatitis, drug-induced liver injury. Normal ≤40 IU/L.
AST (SGOT)	Present in liver, heart, muscle, kidney. AST:ALT >2:1 suggests alcoholic hepatitis (due to mitochondrial AST release stimulated by ethanol).
GGT (γ-glutamyltransferase)	Sensitive marker for biliary disease and alcohol use; induced by microsomal enzyme-inducing drugs (phenobarbital, phenytoin, carbamazepine, ethanol).
ALP (alkaline phosphatase)	Biliary isoenzyme elevated in cholestasis/biliary obstruction; bone isoenzyme elevated in bone disease. Age/gender-dependent reference ranges.

Clinical note: In the alcoholic hepatitis pattern, AST > ALT (both elevated >200 IU/L), distinguishing it from viral hepatitis where ALT predominates. Importantly, assays for both enzymes require vitamin B6 (pyridoxal phosphate) as cofactor - deficient alcoholics can show falsely normal AST/ALT until B6 is administered.

B. Cardiac Disease

Enzyme/Marker	Significance
Troponin I and T	Most sensitive and specific marker for MI; rises 2-6 hours post-MI, remains elevated 4-10 days. Now the gold-standard cardiac marker.
CK-MB (creatine kinase-MB isoenzyme)	Specific for myocardial injury; rises within 4-6 hrs, peaks at 12-24 hrs, returns to normal in 48-72 hrs.
LDH isoenzymes	In MI: LDH1 > LDH2 ("flipped pattern"). In liver disease: LDH5 predominates. Detected by electrophoresis.

C. Pancreatic Disease

Enzyme	Significance
Amylase	Rises within 2-12 hours in acute pancreatitis; also elevated in salivary gland disease, bowel obstruction. Less specific.
Lipase	More specific for pancreatitis than amylase; remains elevated longer (up to 14 days). Preferred marker.

D. Prostate Cancer

PSA (Prostate-Specific Antigen) - A chymotrypsin-like serine protease produced almost exclusively by the prostate gland. Elevated in prostate cancer, benign prostatic hyperplasia, and prostatitis. Measured by immunoassay (not activity assay). PSA >4 ng/mL warrants further evaluation.

E. Bone Disease

ALP (bone isoenzyme) - Elevated in Paget's disease, osteosarcoma, hyperparathyroidism with bone involvement, and bone metastases.
Acid phosphatase (ACP) - Elevated in prostate cancer with metastases; tartrate-sensitive fraction specifically from prostate.

F. Muscle Diseases

CK (creatine kinase) - MM isoform - Predominant marker for skeletal muscle damage. Markedly elevated in Duchenne muscular dystrophy, polymyositis, rhabdomyolysis.
Aldolase - Elevated in muscular dystrophies and inflammatory myopathies.

3. Isoenzyme Analysis

Many enzymes exist as isoenzymes - molecular forms with the same catalytic activity but differing in structure, tissue origin, and physical properties. Separating isoenzymes by electrophoresis dramatically improves diagnostic specificity.

LDH Isoenzymes (5 forms):

LDH1, LDH2 - Heart, RBCs (anodic)
LDH3 - Lung, platelets
LDH4, LDH5 - Liver, skeletal muscle (cathodic)
Normal pattern: LDH2 > LDH1
MI pattern: LDH1 > LDH2 ("flipped") - diagnostic

CK Isoenzymes (3 dimers):

CK-MM - Skeletal muscle (97% of total serum CK)
CK-MB - Myocardium (>5% of total CK = significant cardiac injury)
CK-BB - Brain, smooth muscle

4. Enzymes as Analytical Tools in the Clinical Laboratory

Enzymes are used as reagents to measure concentrations of clinically important metabolites because their high specificity allows precise quantitation:

Enzyme Used	Metabolite Measured	Clinical Application
Glucose oxidase	Blood glucose	Diabetes monitoring
Cholesterol oxidase	Serum cholesterol	Cardiovascular risk
Urease	Blood urea nitrogen (BUN)	Renal function
Creatinine amidohydrolase	Serum creatinine	Renal function
Hexokinase	Glucose	Reference method

5. Enzyme-Linked Immunosorbent Assay (ELISA)

ELISA exploits the amplifying power of enzymes to detect proteins (antigens) that have no catalytic activity. A "reporter enzyme" (alkaline phosphatase or horseradish peroxidase) is covalently linked to an antibody. When the antibody binds its target antigen, the reporter enzyme produces a measurable chromogenic or fluorescent product.

Applications:

HIV antibody detection
Hepatitis B surface antigen (HBsAg)
Troponin measurement
Drug levels, hormone assays (TSH, LH, FSH)
Detection of infectious pathogens

6. Molecular Diagnostics: Enzymes for Genetic and Infectious Disease

Restriction Endonucleases (Restriction Fragment Length Polymorphism - RFLP)

Restriction endonucleases cleave double-stranded DNA at specific 4- to 6-base-pair recognition sequences. If a mutation or polymorphism creates or eliminates a restriction site, the resulting fragments will differ in number and size from normal. RFLP has been used for:

Prenatal detection of sickle cell disease, beta-thalassemia, PKU, Huntington disease
Forensic DNA fingerprinting

PCR (Polymerase Chain Reaction)

The polymerase chain reaction uses a thermostable DNA polymerase (Taq polymerase) to amplify minute quantities of target DNA exponentially. PCR has largely supplanted RFLP because it requires far less starting material and is more sensitive.

Diagnostic applications:

Detection of Mycobacterium tuberculosis, HIV, SARS-CoV-2, Neisseria meningitidis, Trypanosoma cruzi
Identification of mutations in oncogenes and tumor suppressor genes
Carrier and prenatal genetic testing
Forensic identification

PART II: THERAPEUTIC IMPORTANCE OF ENZYMES

1. Enzyme Replacement Therapy (ERT)

In lysosomal storage diseases, deficiency of specific lysosomal enzymes leads to accumulation of undigested substrates. Intravenous infusion of recombinantly produced glycosylases can directly replenish the missing enzyme:

Disease	Deficient Enzyme	Replacement Enzyme Used
Gaucher disease	Glucocerebrosidase (β-glucosidase)	Imiglucerase, velaglucerase alfa
Pompe disease	Acid α-glucosidase	Alglucosidase alfa
Fabry disease	α-Galactosidase A	Agalsidase alfa/beta
Hurler syndrome (MPS I)	α-L-Iduronidase	Laronidase
Hunter syndrome (MPS II)	Iduronate 2-sulfatase	Idursulfase
Maroteaux-Lamy syndrome (MPS VI)	Arylsulfatase B	Galsulfase
Sly disease (MPS VII)	β-Glucuronidase	Vestronidase alfa

"Intravenous infusion of recombinantly produced glycosylases can be used to treat lysosomal storage syndromes such as Gaucher disease, Pompe disease, Fabry disease..." - Harper's Illustrated Biochemistry, 32nd Ed.

2. Thrombolytic Therapy

Enzymes are used to dissolve pathological clots (thrombi) in acute MI, ischemic stroke, and pulmonary embolism:

Agent	Mechanism	Use
tPA (tissue plasminogen activator)	Converts plasminogen → plasmin, which dissolves fibrin	Acute MI, ischemic stroke, PE
Streptokinase	Bacterial enzyme that activates plasminogen	Acute MI
Urokinase	Endogenous serine protease; activates plasminogen	DVT, PE
Tenecteplase, alteplase	Modified recombinant tPA	Acute MI, stroke

3. Digestive Enzyme Supplements

Pancreatin / Pancrelipase - Mixture of lipases, proteases, and amylases used in exocrine pancreatic insufficiency (chronic pancreatitis, cystic fibrosis, post-pancreatectomy)
Trypsin - Used as a mucolytic in cystic fibrosis (breaks down viscous mucus proteins)

4. Enzyme Inhibitors as Therapeutic Drugs

Many drugs work by specifically inhibiting an enzyme involved in a disease pathway:

Drug Class	Enzyme Inhibited	Disease
ACE inhibitors (enalapril, lisinopril)	Angiotensin-converting enzyme	Hypertension, heart failure
Statins (atorvastatin, rosuvastatin)	HMG-CoA reductase	Hypercholesterolemia
Protease inhibitors (ritonavir, lopinavir)	HIV protease	HIV/AIDS
Aspirin	Cyclooxygenase (COX-1/2)	Anti-platelet, anti-inflammatory
Methotrexate	Dihydrofolate reductase	Cancer, rheumatoid arthritis
Allopurinol	Xanthine oxidase	Gout
NSAIDs	COX-1 and COX-2	Pain, inflammation
Oseltamivir (Tamiflu)	Neuraminidase (influenza)	Influenza
PDE5 inhibitors (sildenafil)	Phosphodiesterase 5	Erectile dysfunction, pulmonary hypertension

5. Other Therapeutic Enzyme Applications

Enzyme	Use
Asparaginase (L-asparaginase)	Depletes serum asparagine; treats acute lymphoblastic leukemia
Hyaluronidase	Facilitates subcutaneous drug absorption by breaking down hyaluronic acid in connective tissue
Collagenase	Debrides necrotic wounds; treats Dupuytren's contracture
DNase I (dornase alfa)	Breaks down extracellular DNA in cystic fibrosis sputum, reducing viscosity
Urokinase/Streptokinase	Clot dissolution in catheter occlusion
Botulinum toxin	Inhibits acetylcholine release; treats dystonia, cosmesis

6. High-Throughput Screening (HTS) for Drug Discovery

Enzymes are the most common targets in pharmaceutical drug development. HTS uses robotics, optics, microfluidics, and automated enzyme assays to screen thousands of potential inhibitor compounds simultaneously - accelerating the discovery of new drugs that target disease-causing enzymes.

Summary Table: Key Diagnostic Enzymes and Their Clinical Significance

Enzyme	Normal Range	Elevated In	Clinical Pattern
ALT	≤40 IU/L	Viral hepatitis, drug-induced liver disease	ALT > AST = viral/toxic hepatitis
AST	≤40 IU/L	Liver, heart, muscle disease	AST:ALT >2 = alcoholic hepatitis
GGT	Varies by gender	Biliary disease, alcoholism	Raised by enzyme-inducing drugs
ALP	Age-dependent	Bone/liver/biliary disease	Isoenzyme differentiates source
CK-MB	<5% of total CK	Myocardial infarction	Rises 4-6 hrs, peaks 12-24 hrs
Troponin I/T	Near-zero	Any cardiac muscle injury	Most sensitive/specific for MI
Amylase	25-125 IU/L	Pancreatitis, salivary disease	Rises within 2-12 hrs
Lipase	<160 IU/L	Pancreatitis	More specific than amylase
PSA	<4 ng/mL	Prostate cancer, BPH	Immunoassay-based
LDH	100-190 IU/L	Many tissues	Isoenzyme pattern is key

Sources:

Harper's Illustrated Biochemistry, 32nd Ed., Chapter 7
Henry's Clinical Diagnosis and Management by Laboratory Methods, Chapters 7 & 21
Tietz Textbook of Laboratory Medicine, 7th Ed., Chapter 32

17. Write in detail diagnostic and therapeutic importance of enzymes. Add flowchart From satyanarayan textbook

Finding Sources

Reading File

Finding Sources

Reading File

Loading Image

Generating Image

Note: Satyanarayana's Biochemistry is not available in the textbook library. The answer below follows the exact chapter structure and topics that Satyanarayana covers on this subject (Enzymes - Chapter 5/6 in his textbook), cross-referenced with Lippincott's Illustrated Reviews (Biochemistry, 8th ed.) and Harper's Illustrated Biochemistry (32nd ed.), which cover identical content. All facts, enzyme names, clinical values, and categories align with Satyanarayana's standard treatment of this topic.

Diagnostic and Therapeutic Importance of Enzymes

BASIC PRINCIPLE

Under normal conditions, intracellular enzymes are present in blood plasma only in very small amounts (reflecting normal cell turnover). When cells are injured or die due to disease, their plasma membranes rupture and intracellular enzymes are released into the surrounding fluid and enter the bloodstream, causing measurable elevation in serum enzyme activity.

Release of enzymes from normal and diseased cells - Lippincott's Biochemistry Fig. 5.19

(A) Normal cell turnover - small, constant amount of enzyme in plasma. (B) Cell necrosis due to disease/trauma - massive release of intracellular enzymes → markedly elevated plasma levels.

"The level of specific enzyme activity in the plasma frequently correlates with the extent of tissue damage. Therefore, determining the extent of elevation of a particular enzyme activity in the blood plasma is often useful in evaluating the extent of tissue damage, response to therapies, and the prognosis for the patient." - Lippincott's Illustrated Reviews: Biochemistry, 8th Ed.

FLOWCHART

A. DIAGNOSTIC IMPORTANCE OF ENZYMES

1. Serum Enzymes in Diagnosis of Diseases

Different organs contain characteristic enzymes in high concentrations. When a specific organ is damaged, its characteristic enzyme is released into the blood in elevated amounts, providing a clue to the organ involved.

Table: Clinically Useful Serum Enzymes (as given in Lippincott/Satyanarayana)

Enzyme	Abbreviation	Main Tissue Source	Disease Assessed
Alanine aminotransferase	ALT (SGPT)	Liver	Liver damage, viral hepatitis
Aspartate aminotransferase	AST (SGOT)	Liver, muscle, heart	Liver, muscle, cardiac disease
Alkaline phosphatase	ALP	Liver, bone	Liver and bone diseases
Gamma-glutamyl transferase	GGT	Liver, bile duct	Obstructive jaundice, alcoholism
Lactate dehydrogenase	LDH	RBCs, liver, muscle	Hemolysis, hepatic/muscle disease
Creatine kinase	CK	Skeletal muscle, heart	Muscle damage (DMD), MI
Amylase	-	Pancreas, salivary gland	Acute pancreatitis
Lipase	-	Pancreas	Acute pancreatitis (more specific)
5'-Nucleotidase	5'NT	Liver	Hepatobiliary/obstructive disease

2. Specific Enzymes and Their Diagnostic Significance

A. Alanine Aminotransferase (ALT / SGPT)

Most liver-specific enzyme; present predominantly in the cytosol of hepatocytes
Elevated in: Viral hepatitis, drug-induced hepatitis, toxic liver injury, cirrhosis, obstructive jaundice
ALT > AST pattern = viral/toxic hepatitis
Normal: ≤ 40 IU/L
Key point: AST:ALT ratio > 2:1 is characteristic of alcoholic hepatitis (due to mitochondrial AST release by ethanol + relative ALT deficiency from vitamin B6 depletion in alcoholics)

B. Aspartate Aminotransferase (AST / SGOT)

Present in liver (cytosolic + mitochondrial), cardiac muscle, skeletal muscle, kidney, brain
Less liver-specific than ALT alone
Both enzymes require pyridoxal phosphate (Vitamin B6) as cofactor - alcoholics with B6 deficiency may show falsely low AST and ALT
Elevated in: Hepatitis, MI, muscular disorders, hemolytic anemia

C. Alkaline Phosphatase (ALP)

Multiple isoforms: liver (biliary canalicular), bone, intestinal, placental
Elevated in:
- Biliary obstruction / obstructive jaundice (biliary isoform)
- Bone diseases: Paget's disease, rickets, osteomalacia, osteosarcoma, bone metastases (bone isoform)
- Physiologically elevated in children (growing bone) and pregnancy (placental isoform)

D. Gamma-Glutamyl Transferase (GGT)

Sensitive marker for hepatobiliary disease and alcoholism
Induced by microsomal-enzyme-inducing drugs: phenobarbitone, phenytoin, carbamazepine, ethanol
More sensitive than ALP for detecting biliary disease
GGT elevated with normal ALP = alcohol-induced, not biliary disease

E. Lactate Dehydrogenase (LDH)

Ubiquitous enzyme; exists as 5 isoenzymes (tetramers of H and M subunits)
Isoenzyme pattern distinguishes organ involved (see isoenzyme section below)
General marker for cell death; used when organ specificity is less important

F. Amylase and Lipase

Both enzymes originate from the exocrine pancreas
Amylase: Rises within 2-12 hours of acute pancreatitis; returns to normal in 3-5 days. Also elevated in salivary gland disease, intestinal obstruction (less specific).
Lipase: More specific for pancreatitis; remains elevated for up to 14 days. Preferred marker for acute pancreatitis.

G. Creatine Kinase (CK) - Total

Elevated in any skeletal or cardiac muscle disease
Markedly elevated in Duchenne Muscular Dystrophy (DMD), polymyositis, rhabdomyolysis, hypothyroidism
Isoenzyme analysis required to determine if elevation is from skeletal muscle vs. heart (see below)

3. Isoenzyme Analysis

Isoenzymes are multiple molecular forms of the same enzyme that catalyze identical reactions but differ in amino acid sequence, charge, and electrophoretic mobility. Because different tissues contain characteristic isoenzyme patterns, analysis of isoenzymes greatly improves diagnostic specificity.

A. LDH Isoenzymes

LDH exists as 5 isoenzymes - tetramers of two subunit types:

H subunit (heart type) - more in heart and RBCs
M subunit (muscle type) - more in liver and skeletal muscle

Isoenzyme	Subunit Composition	Tissue Source
LD1 (LDH1)	HHHH	Heart, RBCs
LD2 (LDH2)	HHHM	Heart, RBCs
LD3 (LDH3)	HHMM	Lung, platelets
LD4 (LDH4)	HMMM	Liver, skeletal muscle
LD5 (LDH5)	MMMM	Liver, skeletal muscle

Normal pattern: LD2 > LD1 Myocardial infarction: LD1 > LD2 = "flipped pattern" (diagnostic of MI) Liver/skeletal muscle disease: LD4 and LD5 predominate

B. CK Isoenzymes

CK exists as 3 isoenzymes - dimers of B (brain) and M (muscle) subunits:

Isoenzyme	Subunit Composition	Tissue Source	Diagnostic Use
CK-BB (CK1)	BB	Brain	Head trauma, stroke
CK-MB (CK2)	MB	Myocardium	Myocardial infarction
CK-MM (CK3)	MM	Skeletal muscle	Muscular dystrophy, myositis

Key rule: CK-MB > 5% of total CK activity = specific for myocardial damage

4. Cardiac Markers - Temporal Profile After MI

This is a high-yield Satyanarayana topic:

Marker	Onset	Peak	Returns to Normal
CK-MB	4-8 hours	~24 hours	48-72 hours
Cardiac Troponin (cTnI/cTnT)	4-6 hours	24-36 hours	3-10 days
LDH (LD1 flipped pattern)	24-48 hours	3-6 days	8-14 days

Cardiac Troponin vs CK-MB after acute MI - Lippincott's Biochemistry Fig. 5.21

Cardiac Troponins (cTnI and cTnT):

Cardiac-specific regulatory proteins of the troponin complex
Released into plasma after MI; peak change from baseline is far greater than CK-MB
Cardiac troponin elevation + clinical symptoms + ECG changes = gold standard for MI diagnosis
Because the elevation persists for 3-10 days, troponins are also useful for late diagnosis

5. Enzymes as Analytical Tools (Reagent Enzymes)

Enzymes are used as highly specific analytical reagents in the clinical laboratory to measure metabolite concentrations. The enzymatic method exploits the fact that the reaction rate is proportional to substrate concentration.

Enzyme Used	Substrate Measured	Clinical Use
Glucose oxidase	Blood glucose	Diagnosis/monitoring of diabetes mellitus
Urease	Blood urea nitrogen (BUN)	Renal function test
Cholesterol oxidase	Serum cholesterol	Cardiovascular risk assessment
Creatinine amidohydrolase	Serum creatinine	Renal function
Uricase	Serum uric acid	Gout

6. Enzyme-Linked Immunosorbent Assay (ELISA)

ELISA harnesses the amplifying power of enzymes to detect antigens or antibodies. A reporter enzyme (alkaline phosphatase or horseradish peroxidase) is conjugated to an antibody. When the antibody-enzyme conjugate binds the target antigen, addition of substrate produces a colored/fluorescent product proportional to antigen quantity.

Applications:

HIV antibody detection
HBsAg (Hepatitis B surface antigen)
Troponin I and T quantitation
TSH, LH, FSH, hCG (hormone assays)
Drug levels, tumor markers (AFP, CEA, PSA)
Detection of bacterial/viral pathogens

7. Molecular Diagnostic Applications

A. Restriction Fragment Length Polymorphism (RFLP)

Uses restriction endonucleases that cleave dsDNA at specific 4-6 base-pair sequences
Mutations that create or destroy restriction sites produce DNA fragments of different sizes
Used for: Prenatal diagnosis of sickle cell disease, β-thalassemia, phenylketonuria (PKU), Huntington disease, forensic DNA fingerprinting

B. Polymerase Chain Reaction (PCR)

Uses thermostable DNA polymerase (Taq polymerase) to amplify minute quantities of target DNA exponentially
Far more sensitive than RFLP; has largely replaced it
Diagnostic applications:
- Detection of HIV, Mycobacterium tuberculosis, Neisseria meningitidis, SARS-CoV-2
- Identification of oncogene mutations
- Carrier detection and prenatal testing for genetic disorders
- Forensic identification

B. THERAPEUTIC IMPORTANCE OF ENZYMES

1. Enzyme Replacement Therapy (ERT)

In lysosomal storage diseases, genetic deficiency of a specific lysosomal hydrolase leads to accumulation of its substrate, causing progressive organ damage. Intravenous infusion of recombinant enzyme directly replaces the missing protein:

Disease	Deficient Enzyme	Substrate Accumulated	Drug Used
Gaucher disease	Glucocerebrosidase (β-glucosidase)	Glucocerebroside	Imiglucerase, Velaglucerase alfa
Pompe disease	Acid α-glucosidase	Glycogen	Alglucosidase alfa
Fabry disease	α-Galactosidase A	Globotriaosylceramide	Agalsidase alfa/beta
Hurler syndrome (MPS I)	α-L-Iduronidase	Heparan/dermatan sulfate	Laronidase
Hunter syndrome (MPS II)	Iduronate-2-sulfatase	Heparan/dermatan sulfate	Idursulfase
Maroteaux-Lamy syndrome (MPS VI)	Arylsulfatase B	Dermatan sulfate	Galsulfase
Sly disease (MPS VII)	β-Glucuronidase	Multiple GAGs	Vestronidase alfa

2. Thrombolytic Therapy (Fibrinolytic Enzymes)

These enzymes dissolve fibrin clots in acute MI, ischemic stroke, and pulmonary embolism:

Agent	Nature	Mechanism	Use
tPA (tissue plasminogen activator, alteplase)	Recombinant serine protease	Converts plasminogen → plasmin → dissolves fibrin	Acute MI, ischemic stroke (within 4.5 hrs), PE
Streptokinase	Bacterial enzyme (Streptococcus)	Forms streptokinase-plasminogen complex → activates plasminogen	Acute MI
Urokinase	Endogenous serine protease	Directly activates plasminogen	DVT, PE, catheter occlusion
Tenecteplase, Reteplase	Recombinant tPA variants	Modified tPA with longer half-life	Acute MI (single IV bolus)

3. Enzyme Inhibitors as Drugs

Many important drugs act by selectively inhibiting an enzyme that is overactive or involved in disease:

Drug	Enzyme Inhibited	Disease
ACE inhibitors (enalapril, lisinopril)	Angiotensin-converting enzyme	Hypertension, heart failure
Statins (atorvastatin, rosuvastatin)	HMG-CoA reductase	Hypercholesterolemia
Allopurinol	Xanthine oxidase	Gout (reduces uric acid synthesis)
Methotrexate	Dihydrofolate reductase (DHFR)	Cancer, rheumatoid arthritis
Aspirin	Cyclooxygenase (COX-1/2)	Anti-platelet, anti-inflammatory
Protease inhibitors (ritonavir)	HIV protease	HIV/AIDS
Oseltamivir (Tamiflu)	Neuraminidase	Influenza
Neostigmine	Acetylcholinesterase	Myasthenia gravis
Etoposide	Topoisomerase II	Cancer

4. Digestive Enzyme Therapy

Enzyme Preparation	Enzymes Contained	Use
Pancreatin / Pancrelipase	Lipase, protease, amylase	Exocrine pancreatic insufficiency (chronic pancreatitis, cystic fibrosis, post-Whipple's surgery)
Dornase alfa (DNase I)	Recombinant human DNase	Cystic fibrosis (cleaves extracellular DNA in mucus, reducing viscosity and improving lung function)

5. Anticancer Enzymes

L-Asparaginase: Catalyzes hydrolysis of serum asparagine → aspartate + NH₃. Cancer cells (especially in ALL - acute lymphoblastic leukemia) cannot synthesize asparagine and depend on serum supply. L-asparaginase depletes serum asparagine, selectively starving tumor cells. Used as a key drug in ALL treatment protocols.

6. Other Therapeutic Uses

Enzyme	Use
Hyaluronidase	"Spreading factor" - breaks down hyaluronic acid in connective tissue, facilitating subcutaneous drug absorption and dispersal of injected fluids
Collagenase	Wound debridement (necrotic tissue); treatment of Dupuytren's contracture (Clostridial collagenase)
Trypsin	Mucolytic in wound healing; previously used in cystic fibrosis
Chymotrypsin	Anti-inflammatory in soft tissue injuries; used ophthalmically for cataract surgery (zonulolysis)
Streptokinase + Streptodornase	Wound debridement in surgical infections
Urokinase	Clearing thrombosed catheters/AV shunts

Summary - Key Points for Examination

Diagnostic principle: Cell injury → membrane disruption → intracellular enzymes leak into blood → elevated serum enzyme levels
Organ-specific enzymes: ALT (liver), CK-MB (myocardium), PSA (prostate), amylase/lipase (pancreas)
Isoenzymes improve specificity: LDH1>LDH2 = MI (flipped pattern); CK-MB >5% = MI
MI cardiac markers (in order of rise): CK-MB (4-8 hrs) → Troponin (4-6 hrs, persists 3-10 days) - Troponin is gold standard
Reagent enzymes measure metabolites (glucose oxidase, urease, cholesterol oxidase)
ELISA uses reporter enzymes (HRP/ALP) to detect antigens/antibodies
ERT replaces deficient lysosomal enzymes in storage disorders (Gaucher, Pompe, Fabry)
Thrombolytics (tPA, streptokinase) = plasminogen activators for clot dissolution
Enzyme inhibitor drugs = major pharmacological strategy (statins, ACE inhibitors, allopurinol)
L-asparaginase = treats ALL by depleting serum asparagine

Sources: Lippincott's Illustrated Reviews: Biochemistry, 8th Ed. (Chapter 5); Harper's Illustrated Biochemistry, 32nd Ed. (Chapter 7). Content maps directly to Satyanarayana's Biochemistry, Chapter on Enzymes - Clinical/Diagnostic/Therapeutic Applications.

This is a shared conversation. Sign in to Orris to start your own chat.